Publications in collaboration with researchers from Instituto de Investigación Sanitaria del Principado de Asturias (66)

2024

  1. Auritidibacter ignavus in ear discharge of paediatric patients: Two cases reports and literature review

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 4, pp. 202-204

  2. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma

    Cells, Vol. 13, Núm. 1

  3. Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  4. Experimental Models of Sinonasal Tumors for Preclinical Testing of Candidate Targeted Therapies

    Current Otorhinolaryngology Reports, Vol. 12, Núm. 1, pp. 1-10

  5. Lectin-like Transcript-1 (LLT1) Expression in Oral Squamous Cell Carcinomas: Prognostic Significance and Relationship with the Tumor Immune Microenvironment

    International journal of molecular sciences, Vol. 25, Núm. 8

  6. Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with Head and Neck Cutaneous Squamous Cell Carcinoma

    International Journal of Molecular Sciences, Vol. 25, Núm. 8

  7. Next-generation sequencing reveals remarkable genetic stability in primary and corresponding recurrent intestinal-type sinonasal adenocarcinoma

    Head and Neck

  8. Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma

    European Archives of Oto-Rhino-Laryngology, Vol. 281, Núm. 2, pp. 945-951

  9. Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis

    Journal of translational medicine, Vol. 22, Núm. 1, pp. 135

  10. VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. A Novel External Auditory Canal Squamous Cell Carcinoma Cell Line Sensitive to CDK4/6 Inhibition

    Otolaryngology - Head and Neck Surgery (United States), Vol. 168, Núm. 4, pp. 729-737

  2. Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

    Molecular Cancer, Vol. 22, Núm. 1

  3. Chemo-Immunotherapy: A New Trend in Cancer Treatment

    Cancers, Vol. 15, Núm. 11

  4. Complications related to the Cook–Swartz implantable Doppler probe use in head and neck microvascular reconstruction: a systematic review

    European Archives of Oto-Rhino-Laryngology, Vol. 280, Núm. 1, pp. 23-37

  5. Correction to: Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review (Advances in Therapy, (2023), 40, 9, (3681-3696), 10.1007/s12325-023-02561-7)

    Advances in Therapy

  6. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment

    Biomedicine and Pharmacotherapy, Vol. 161

  7. Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics

    Biomedicine and Pharmacotherapy, Vol. 158

  8. Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  9. Neutrophil to Lymphocyte Ratio in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis †

    Cancers, Vol. 15, Núm. 3

  10. Novel Imaging-Based Biomarkers for Identifying Carotid Plaque Vulnerability †

    Biomolecules, Vol. 13, Núm. 8